BCDA
BioCardia, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Peter A. Altman
IPO Date
1996-11-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BioCardia, Inc.
CEO
Peter A. Altman
IPO Date
1996-11-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,500 |
| $0.92 |
| 18 May 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 5,700 | $0.92 |
| 15 May 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 5,100 | $1.02 |
| 29 Apr 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 5,000 | $1.11 |
| 22 Apr 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 600 | $1.23 |
| 22 Apr 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 400 | $1.23 |
| 26 Mar 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 600 | $1.24 |
| 26 Mar 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 300 | $1.22 |
| 4 Feb 2026 | Altman Peter | director, officer: President and CEO | P-Purchase | Acquired | 5,000 | $1.13 |